Alluvi tirzepatide has been emerged as a promising therapeutic candidate for the treatment of metabolic diseases. This preclinical evaluation assessed the efficacy and profile of tirzepatide 40mg in animal models of metabolic syndrome. The studies demonstrated that tirzepatide 40mg substantially enhanced glycemic control and lowered insulin sensiti